Arkansas Administrative Code › Agency 007 - ARKANSAS DEPARTMENT OF HEALTH › Division 07 - Pharmacy Services › Rule 007.07.19-003 - Rules Pertaining to Controlled Substances List

Current through Register Vol. 49, No. 6, June, 2024
SECTION I
AUTHORITY
The following scheduling of these controlled substances has
				been hereby promulgated pursuant to Arkansas Stat. Ann. § 5-64-201 and
				§ 5-64-216.
SECTION II
PURPOSE
Due consideration has been given applicable Federal
				regulations, current scientific knowledge regarding the listed substances, the
				evidence of actual or relative potential for abuse, the history and current
				patterns of abuse, the risk to the public health, and potential to produce
				psychic or psychological dependence liability.
SECTION III
GENERAL REQUIREMENTS
(Attached copy of the listing of scheduling of controlled
				substances)
SECTION IV
REPEAL
All lists of schedules of controlled substances in conflict
				herewith are hereby repealed.
ARTICLE
			 II
Schedule I
(a) Schedule I shall consist of the drugs and
			 other substances, by whatever official name, common or usual name, chemical
			 name, or brand name designated, listed in this section. Each drug or substance
			 has been assigned the DEA Controlled Substances Code Number set forth opposite
			 it.
(b)
Opiates:
			 (Narcotic Drugs)
Unless specifically excepted or unless
			 listed in another schedule, any of the following opiates, including their
			 isomers, esters, ethers, salts, and salts of isomers, esters, and ethers,
			 whenever the existence of such isomers, esters, ethers, salts is possible
			 within the specific chemical designation (for purposes of 3-methylthiofentanyl
			 only, the term isomer includes the optical and geometric isomers):
(1)
			 Acetyl-alpha-methylfentanyl(N-[1-[1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide)
			 ----- 9815-(2-86)
(2)
			 Acetylmethadol------------------------------------- 9601*
(3) Allylprodine
			 --------------------------------------- 9602*
(4) Alphacetylmethadol (except
			 Levo-alphacetylmethadol (LAAM) ----------------------------------------------
			 9603*
(5) Alphameprodine
			 ------------------------------------- 9604*
(6) Alphamethadol
			 -------------------------------------- 9605*
(7) Alpha-methylfentanyl
			 (N-[1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl] propronanilide;
			 1-(1-methyl-2-phenylethyl)-4(N-propanilido) piperidine) -------
			 9814-(6-82)
(8)
			 Alpha-methylthiofentanyl (N-[1-methyl-2-(2thienyl)
			 ethyl-4-piperidinyl]-N-phenylpropanamide) -------- 9832-(2-86)
(9) Benzethidine
			 --------------------------------------- 9606*
(10) Betacetylmethadol
			 ---------------------------------- 9607*
(11) Beta-hydroxyfentanyl
			 (N-[1-(2-hydroxy-2-phenethyl) -4-piperidinyl [ ] -N-phenylpropanamide)
			 ------------- 9830-(2-86)
(12)
			 Beta-hydroxy-3-methylfentanyl [other name:
			 N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropamamide]
			 --------------- 9831-(2-86)
(13)
			 Betameprodine -------------------------------------- 9608*
(14) Betamethadol
			 --------------------------------------- 9609*
(15) Betaprodine
			 ---------------------------------------- 9611*
(16) Clonitazene
			 ---------------------------------------- 9612*
(17) Dextromoramide
			 ------------------------------------- 9613*
(18) Diampromide
			 ---------------------------------------- 9615*
(19) Diethylthiambutene
			 --------------------------------- 9616*
(20) Difenoxin
			 ------------------------------------------ 9168*
(21) Dimenoxadol
			 ---------------------------------------- 9617*
(22) Dimepheptanol
			 -------------------------------------- 9618*
(23) Dimethylthiambutene
			 ------------------------------- 9619*
(24) Dioxaphetyl butyrate
			 ------------------------------ 9621*
(25) Dipipanone
			 ----------------------------------------- 9622*
(26) Ethylmethylthiambutene
			 ---------------------------- 9623*
(27) Etonitazene
			 ---------------------------------------- 9624*
(28) Etoxeridine
			 ---------------------------------------- 9625*
(29) Furethidine
			 ---------------------------------------- 9626*
(30) Hydroxypethidine
			 ----------------------------------- 9627*
(31) Ketobemidone
			 --------------------------------------- 9628*
(32) Levomoramide
			 --------------------------------------- 9629*
(33) Levophenacylmorphan
			 ------------------------------- 9631*
(34) 3-Methylfentanyl
			 (N-[3-Methyl-1-(2-phenylethyl)-4-piperidyl]-N-Phenylpropanamide)
			 ------------------- 9813-(10-85)
(35) 3-methylthiofentanyl
			 (N-[(3-methyl-1-(2-thienyl) ethyl-4-piperidinyl]-N-phenylpropanamide) --------
			 9833-(2-86)
(36) Morpheridine
			 --------------------------------------- 9632*
(37) MPPP
			 (1-methyl-4-phenyl-4-propionoxypiperidine) --- 9661-(10-85)
(38) Noracymethadol
			 ------------------------------------- 9633*
(39) Norlevorphanol
			 ------------------------------------- 9634*
(40) Normethadone
			 --------------------------------------- 9635*
(41) Norpipanone
			 ---------------------------------------- 9636*
(42) Para-fluorofentanyl
			 (N-[4-fluorophenyl)-N-[1-(2-phenenthyl)-4-piperindinyl]propananmide ----------
			 9812-(11-86)
(43) PEPAP
			 1-(2-phenylethyl)-4-phenyl-4 acetyloxypiperidine
			 ---------------------------------------------- 9663-(10-85)
(44) Phenadoxone
			 ---------------------------------------- 9637*
(45) Phenampromide
			 -------------------------------------- 9638*
(46) Phenomorphan
			 ---------------------------------------9647*
(47) Phenoperidine
			 -------------------------------------- 9641*
(48) Piritramide
			 ---------------------------------------- 9642*
(49) Proheptazine
			 --------------------------------------- 9643*
(50) Properidine
			 ---------------------------------------- 9644*
(51) Propiram
			 ------------------------------------------- 9649*
(52) Racemoramide
			 --------------------------------------- 9645*
(53) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)
			 ethyl-4-piperidinyl] -propanamide --------------------------
			 9835-(2-86)
(54) Tilidine
			 ------------------------------------------- 9750-(9-81)
(55) Trimeperidine
			 -------------------------------------- 9646*
(56) Acetyl fentanyl
			 N-(1-phenethylpiperidin-4-yl) -N-phenylacetamide
			 -----------------------------------9821
(57) Butyryl fentanyl
			 N-(1-phenethylpiperidin-4-yl) -N-pheny lbutyr amide
			 ---------------------------------- 9822
(58) Beta-hydroxythiofentanyl
			 N-{1-[2-hydroxy-2-(thiophen-2-yl) ethyl] piperidin-4-yl}-N-phenylpropionamide
			 ----------------------------------- 9836
(59) Acetyl fentanyl 4-methylphenethyl analog
			 N-{1-[2-(4-methylphenyl) ethyl]-4-piperidinyl} -N-phenyl-acetamide
			 monohydrochloride
(60) Valeryl
			 fentanyl N-phenyl-N [1-(2-phenylethyl) -4-piperidinyl] -pentanamide
			 monohydrochloride
(61) Furanyl
			 fentanyl N-(1-(2-phenylethyl) -4-piperidinyl)-N-phenylfuran-2-carboxamide
			 --------- 9834
(62) Isobutyryl
			 fentanyl 2-methyl-N-phenyl-N-[1-(2-phenylethyl) -4-piperidinyl] -propanamide
			 monohydrochloride
(63) Ocfentanil
			 N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl) piperidin-4-yl] acetamide
			 ---------------- 9838
(64)
			 4-methoxy butyryl fentanyl N-(4-methoxyphenyl)-N -(1-phenethylpiperidin-4-yl)
			 butyramide monohydro chloride
(65)
			 Para-fluorobutyryl fentanyl
			 N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-butanamide mono
			 hydrochloride
(66) Acetyl
			 norfentanyl N-phenyl-N-4-piperidinyl-acetamide monohydrochloride
(67) AH-7921 3,4-dichloro-N-
			 [(ldimethylamino) cyclohexyl methyl] benzamide
(68) W-18
			 1-(4-nitrophenylethyl)piperidylidene-2-(4-chlorophenyl) sulfonamide
(69) W-15
			 l-phenylethylpiperidylidene-2-(4-chlorophenyl) sulfonamide
(70) MT-45 1-cyclohexyl-4-(1,2-diphenylethyl)
			 piperazine
(71) U-47700
			 trans-3,4-dichloro-N-(2-(dimethylamino) cyclohexyl)-N-methylbenzamide
(72) Acryl fentanyl
			 N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide
			 ------------------------------------ 9811
(73) 4-Fluoroisobutyryl fentanyl
			 N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) isobutyramide ----------
			 9824
(74) Tetrahydrofuranyl
			 fentanyl N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide
			 ------- 9843
(c)
Opium derivatives
:
(Narcotic
			 Drugs
)
Unless specifically excepted or unless listed in
			 another schedule, any of the following opium derivatives, its salts, isomers,
			 and salts of isomers whenever the existence of such salts, isomers, and salts
			 of isomers is possible within the specific chemical designation:
(1) Acetorphine
			 ---------------------------------------- 9319*
(2) Acetyldihydrocodeine
			 ------------------------------- 9051*
(3) Benzylmorphine
			 ------------------------------------- 9052*
(4) Codeine methylbromide
			 ----------------------------- 9070*
(5) Codeine-N-Oxide
			 ------------------------------------ 9053*
(6) Cyprenorphine
			 -------------------------------------- 9054*
(7) Desomorphine
			 --------------------------------------- 9055*
(8) Dihydromorphine
			 ------------------------------------ 9145*
(9) Drotebanol
			 ----------------------------------------- 9335*
(10) Etorphine (except hydrochloride salt)
			 ------------- 9056*
(11) Heroin
			 --------------------------------------------- 9200*
(12) Hydromorphinol
			 ------------------------------------- 9301*
(13) Methyldesorphine
			 ----------------------------------- 9302*
(14) Methyldihydromorphine
			 ----------------------------- 9304*
(15) Morphine methylbromide
			 ---------------------------- 9305*
(16) Morphine methylsulfonate
			 -------------------------- 9306*
(17) Morphine-N-Oxide
			 ----------------------------------- 9307*
(18) Myrophine
			 ------------------------------------------ 9308*
(19) Nicocodeine
			 ---------------------------------------- 9309*
(20) Nicomorphine
			 --------------------------------------- 9312*
(21) Normorphine
			 ---------------------------------------- 9313*
(22) Pholcodine
			 ----------------------------------------- 9314*
(23) Thebacon
			 ------------------------------------------- 9315*
(24) Mitragynine
(25) 7-Hydroxymitragynine
(d)
Hallucinogenic substances
: Unless
			 specifically excepted or unless listed in another schedule, any material,
			 compound, mixture, or preparation, which contains any quantity of the following
			 hallucinogenic substance, or which contains any of its salts, isomers, and
			 salts of isomers whenever the existence of such salts, isomers, and salts of
			 isomers is possible within the specific chemical designation (for purposes of
			 this paragraph only, the term "isomer" includes the optical, position and
			 geometric isomers):
(1) alpha-ethyltryptamine
			 ------------------------------- 7249-(12-93)
Some trade or other names: etryptamine; Monase;
				alpha-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; alpha-ET; and
				AET.
(2)
			 4-bromo-2,5-dimethoxy-amphetamine ------------------- 7391*
Some trade or other names:
				4-bromo-2,5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2,5-DMA.
(3)
			 4-bromo-2,5-dimethoxyphenethylamine -----------------7392-(8-95)
Some trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1
				aminoethane; alpha-desmethyl DOB; 2C-B, Nexus.
(4) 2,5-dimethoxyamphetamine
			 ---------------------------- 7396*
Some trade or other names:
				2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA.
(5)
			 2,5-dimethoxy-4-ethylamphetamine--------------------7399-(3-88)
Some trade or other names: DOET.
(6)
			 2,5-dimethoxy-4-(n)-propylthiophenethy1amine --------7348- (1-05)
Some trade or other names: 2C-T-7.
(7) 4-methoxyamphetamine
			 --------------------------------- 7411*
Some trade or other names:
				4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine; PMA.
(8)
			 5-methoxy-3,4-methylenedioxy-amphetamine ----------- 7401*
(9) 4-methyl-2,5-dimethoxyamphetamine
			 ------------------- 7395*
Some trade and other names:
				4-methyl-2,5-dimethoxy-alphamethylphenethylamine; "DOM"; and "STP".
(10) 3,4-methylenedioxy
			 amphetamine ---------------------- 7400*
(11) 3,4-methylenedioxymethamphetamine
			 ------------------- 7405-(10-85)
Some trade or other names: MDMA)
(12) 3,4-methylenedioxy-N-ethylamphetamine
			 ---------------7404-(6-90)
Some trade or other names: N- ethy-alpha-methyl-3,4
				(methylenedioxy) phenethylamine, N-ethyl MDA; MDE; MDEA.
(13) N-hydroxy-3,4-methylenedioxyamphetamine
			 ------------- 7402-(6-90)
Some trade or other names: N-hydroxy-alpha-methyl-3,
				4(methylenedioxy) phenethylamine; N-hydroxy MDA
(14) 3,4,5-trimethoxy amphetamine
			 ------------------------ 7390*
(15)
			 5-methoxy-n,n-dimethyltryptamine 5-MeO-DMT---------- 7431* (01-11)
(16) alpha-methyltryptamine
			 ------------------------------ 7432-(7-05)
Some trade or other names: AMT
(17)
			 Bufotenine-------------------------------------------7433*
Some trade and other names: 3-(beta-Dime thy laminoe thy 1
				)-5-hydroxyindole; 3-(2-dimethylaminoethy1)-5-indolol; N,N-dimethylserotonin;
				5-hydroxy-N,N-dimethyltryptamine; mappine.
(18) Diethyltryptamine
			 ------------------------------------ 7434*
Some trade or other names: N,N-Diethyltryptamine; DET.
(19) Dimethyltryptamine
			 -----------------------------------7435*
Some trade or other names: DMT
(20) 5-methoxy-N,N-diisopropyltryptamine
			 -----------------7439-(7-05)
Some trade or other names: 5-MeO-DIPT.
(21) Ibogaine
			 ---------------------------------------------7260*
Some trade and other names: 7-Ethyl-6,6 beta; 7,8,9,
				10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1',2': 1,2] azepino [5,4-b]
				indole; Tabernanthe iboga.
(22) Lysergic acid diethylamide
			 --------------------------7315*
(23) Mescaline
			 --------------------------------------------7381*
(24) Parahexyl
			 --------------------------------------------7374-(7-83)
Some trade or other names:
				3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo [b,d] pyran;
				Synhexyl.
(25) Peyote
			 -----------------------------------------------7415*
Meaning all parts of the plant presently classified botanically
				as Lophophora williamsii Lemaire, whether growing or not; the seeds thereof;
				any extract from any part of such plant; and every compound, manufacture,
				salts, derivative, mixture or preparation of such plant, its seeds or extracts.
				(Interprets
				21 USC
				812(c), Schedule I (c)
				(12)).
(26)
			 N-ethyl-3-piperidyl benzilate ----------------------- 7482*
(27) N-methyl-3-piperidyl benzilate
			 ---------------------- 7484*
(28)
			 Psilocybin -------------------------------------------7437*
(29) Psilocyn
			 ---------------------------------------------7438*
(30) Ethylamine Analog of phencyclidine
			 ------------------ 7455*
Some trade or other names: N-ethyl-1-phenylcyclohexylamine,
				(phenylcyclohexyl) ethylamine; N-(1-phenylcyclohexyl) ethylamine;
				cyclohexamine; PCE.
(31)
			 Pyrrolidine Analog of phencyclidine ----------------- 7458*
Some trade or other names: 1-(1-phenylcyclohexyl) -pyrrolidine;
				PCPy; PHP
(32) Thiophene
			 Analog of phencyclidine ------------------- 7470*
Some trade or other names: 1-[1-(2-thienyl) cyclohexyl]
				Piperidine; 2-Thienyl analog of phencyclidine; TPCP; TCP.
(33) 1-[1-(2-Thienyl)cylcohexyl]pyrrolidine
			 --------------7473-(9-89)
Some other trade or other names: TCPy.
(34) N,N-Diallyl-5-Methoxytryptamine; Some
			 trade or other names: 5-MeO DALT; 5-Methoxy-DALT.
(35)
			 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl] ethanamine;
			 25C-NBOMe
(36)
			 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl] ethanamine;
			 251-NBOMe
(37)
			 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine; 2C-E ----- 7509
(38) 2-(2,5-Dimethoxy-4-methylphenyl)
			 ethanamine; 2C-D ---- 7508
(39)
			 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine; 2C-C ---- 7519
(40) 2-(4-Iodo-2,5-dimethoxyphenyl)
			 ethanamine; 2C-1 ------ 7518
(41)
			 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine;
			 2C-T-2------------------------------------------------7 38 5
(42)
			 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine; 2C-T-4
			 ------------------------------------------------ 7 532
(43) 2-(2, 5-Dimethoxyphenyl) ethanamine;
			 2C-H -------------- 7517
(44)
			 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine; 2C-N ---- 7521
(45) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)
			 ethanamine; 2C-P --------------------------------------------------7 52
			 4
(46)
			 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine;
			 25B-NBOMe
(47)
			 2-[[[2-(4-bromo-2,5-dimethoxyphenyl) ethyl] amino]methyl]-phenol;
			 25B-NBOH
(48)
			 2-[[[2-(4-iodo-2,5-dimethoxyphenyl) ethyl]amino]methyl]-phenol;
			 25I-NBOH
(49)
			 2-(4-ethyl-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine;
			 25E-NBOMe
(50)
			 2-(2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine;
			 25H-NBOMe
(51)
			 2-[[[2-(4-chloro-2,5-dimethoxyphenyl) ethyl]amino]methyl]-phenol;
			 25C-NBOH
(52)
			 2-[[[2-(2,5-dimethoxyphenyl)ethyl]amino]methyl]-phenol; 25H-NBOH
(e)
Depressants
: Unless specifically excepted
			 or unless listed in another schedule, any material, compound, mixture, or
			 preparation which contains any quantity of the following substances having a
			 depressant effect on the central nervous system, including its salts, isomers,
			 and salts of isomers whenever the existence of such salts, isomers, and salts
			 of isomers is possible within the specific chemical designation:
(1) Phenazepam
(2) gamma-hydroxybutyric acid (some other
			 names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxydutanoic
			 acid; sodium oxybate; sodium oxybutyrate), and its known precursors and analogs
			 - 2010-(2-01)
(3) Mecloqualone
			 ------------------------------------------ 2572*
(4) Methaqualone
			 ------------------------------------------ 2565*
(5) Elizulam
(f)
Stimulants
:
(a) Unless specifically excepted or unless
			 listed in another schedule, any material, compound, mixture, or preparation
			 which contains any quantity of the following substances having a stimulant
			 effect on the central nervous system, including its salts, isomers, and salts
			 of isomers:
(1) Cathinone
			 --------------------------------------------- 1235-(3-88)
(2) (+) CIS-4-Methylaminorex
			 [(+)CIS-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine] ----------------------
			 1590-(6-90)
(3) Fenethylline
			 ------------------------------------------ 1503-(9-81)
(4) N-Benzylpiperazine
			 ------------------------------------- 7493- (1-05)
Some trade or other names: BZP, 1-Benzylpiperazine
(5) N-ethylamphetamine
			 ------------------------------------ 1475-(6-82)
(6)
			 N-[1-(1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical
			 isomers, salts and salts of isomers
			 --------------------------------------9818-(2-86)
(7)
			 N-[1-(2-thienyl)methyl-4-piperidyl)-N-phenylpropan-mide (thenylfentanyl), its
			 optical isomers, salts and salts of isomers ----------------------------------
			 9834-(2-86)
(8) N, N,
			 Dimethylamphetamine (some other names: N, N Alpha-trimethylbenzeneethanamine;
			 N, N, Alpha-trimethylphenethylamine), its salts, optical isomers, and salts of
			 optical isomers ----------------1480-(2-89)
(9) Methcathinone (some other names:
			 2-Methylamine-Proprophenone, alpha (methylamino)-Proprophenone, 2
			 (methylamino)-1-phenylpropan-1-one, alpha-N-Methylaminopropiophenone,
			 monomethylpropion, ephedrone, N-methylcathinone, methycathinone, AL-464,
			 AL-422, AL-463 and UR-1431), its salts, optical isomers and salts of optical
			 isomers ----------------- 1237-(12-93)
(10) Aminorex (some other names: aminoraphen,
			 2-amino-5 phenyl-2-oxazoline, or 4,5 dihyrdo-5-phenyl-2-oxazolamine, its salts,
			 optical isomers, and salts of optical isomers
			 ------------------------------------ 1585-(12-93)
(11) Methyl-N-ethylcathinone (MEC)
(b) Any material, compound,
			 mixture, or preparation, whether produced directly or indirectly from a
			 substance of vegetable origin or independently by means of chemical synthesis
			 or by a combination of extraction and chemical synthesis, that contains any
			 quantity of the following substances, or that contains any of the following
			 substances' analogs, salts, isomers, and salts of isomers when the existence of
			 the analogs, salts, isomers, and salts of isomers is possible within the
			 specific chemical designation, with the following chemical structure is
			 included in Schedule I:
(1)
			 4-Methylmethcathinone (Mephedrone) ------------------- 1248-(3-11)
(2) Methylenedioxypyrovalerone (MDPV)
			 ------------------------- (3-11)
(3) 3,4-Methylenedioxy-N-methylcathinone
			 (Methylone) -----7540-(3-11)
(4)
			 4-Methoxymethcathinone -------------------------------- (3-11)
(5) 3-Fluoromethcathinone
			 --------------------------------- (3-11)
(6) 4-Fluoromethcathinone or
			 ----------------------------- (3-11)
(7) 1-(1,3-benzodioxol-5-yl)-2-methylamino)
			 butan-1-one (Butylone)
(8)
			 Alpha-Pyrrolidinopentiophenone (Alpha-PVP)
(9) 4-methyl-N-ethylcathinone
			 (4-MEC)
(10)
			 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP)
(11) 2-(methylamino)-1-phenylpentan-1-one
			 (Pentedrone)
(12)
			 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (Pentylone,MBDP)
(13) 4-fluoro-N-methylcathinone (4-FMC,
			 Flephedrone)
(14)
			 3-fluoro-N-methylcathinone (3-FMC)
(15)
			 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (Naphyrone)
(16) Alpha-pyrrolidinobutiophenone
			 ([Alpha]-PBP) or
(17) A compound,
			 unless listed in another schedule or a legend drug, that is structurally
			 derived from 2-Amino-phenyl-1-propanone by modification or by substitution:
(A) In the phenyl ring to any extent with
			 alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not
			 further substituted in the phenyl ring by one (1) or more other univalent
			 substituents;
(B) At the 3-position
			 with an alkyl substituent; or
(C)
			 At the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the
			 nitrogen atom in a cyclic structure.
(18) N-Ethylpentylone, or
			 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one
Schedule II
(a) Schedule II shall consist of the drugs
			 and other substances, by whatever official name, common or usual name, chemical
			 name, or brand name designated, listed in this section. Each drug or substance
			 has been assigned the Controlled Substances Code Number set forth opposite
			 it.
(b)
Narcotic
			 Drugs
: Substances, vegetable origin or chemical synthesis.
			 Unless specifically excepted or unless listed in another schedule, any of the
			 following substances whether produced directly or indirectly by extraction from
			 substances of vegetable origin, or independently by means of chemical
			 synthesis, or by combination of extraction and chemical synthesis:
(1) Opium and opiate, and any salt, compound,
			 derivative, or preparation of opium or opiate, excluding apomorphine,
			 dextrorphan, nalbuphine, nalmefene, naloxone and naltrexone and their
			 respective salts, but including the following:
(1) Raw opium
			 ---------------------------------------- 9600*
(2) Opium extracts
			 ----------------------------------- 9610*
(3) Opium fluid extracts
			 ---------------------------- 9620*
(4) Powdered opium
			 ----------------------------------- 9639*
(5) Granulated opium
			 --------------------------------- 9640*
(6) Tincture of opium
			 ------------------------------- 9630*
(7) Codeine
			 ------------------------------------------ 9050*
(8) Dihydroetorphine
			 ----------------------------------- 9334*
(9) Ethylmorphine
			 ------------------------------------ 9190*
(10) Etorphine hydrochloride
			 ------------------------- 9059*
(11) Hydrocodone
			 -------------------------------------- 9193*
(12) Hydromorphone
			 ------------------------------------ 9150*
(13) Metopon
			 ------------------------------------------ 9260*
(14) Morphine
			 ----------------------------------------- 9300*
(15) Oripavine
			 ---------------------------------------- 9330*(9-07)
(16) Oxycodone
			 ---------------------------------------- 9143*
(17) Oxymorphone
			 -------------------------------------- 9652*
(18) Thebaine
			 ----------------------------------------- 9333*
(19) Tapentadol
			 --------------------------------------- 9780-(5-09)
(2) Any salt, compound, derivative, or
			 preparation thereof which is chemically eguivalent or identical with any of the
			 substances referred to in paragraph (b) (1) of this section, except that these
			 substances shall not include the isoquinoline alkaloids of opium.*
(3) Opium poppy and poppy straw.*
(4) Coca leaves (9040) and any salt,
			 compound, derivative, or preparation of coca leaves, (including cocaine (9041)
			 and ecgonine (9180) and their salts, isomers, derivatives and salts of isomers
			 and derivatives), and any salt, compound, derivative, or preparation thereof
			 which is chemically equivalent or identical with any of these substances,
			 except that the substances shall not include decocainized coca leaves or
			 extraction of coca leaves, which extractions do not contain cocaine or
			 ecgonine.*
(5) Concentrate or poppy
			 straw (the crude extract of poppy straw in either liquid, solid or powder form
			 which contains the phenanthrine alkaloids of the opium poppy), 9670.*
(c)
Opiates
: (
Narcotic
			 Drugs
)
Unless specifically excepted or unless in another
			 schedule, any of the following opiates, including its isomers, esters, ethers,
			 salts, and salts of isomers, esters and ethers whenever the existence of such
			 isomers, esters, ethers, and salts is possible within the specific chemical
			 designations:
(1) Alfentanil
			 -------------------------------------------- 9737-(2-87)
(2) Alphaprodine
			 ------------------------------------------ 9010*
(3) Anileridine
			 ------------------------------------------- 9020*
(4) Bezitramide
			 ------------------------------------------- 9800*
(5) Bulk Dextropropoxyphene (non-dosage
			 forms) ---------- 9273-(9-81)
(6)
			 Carfentanil ------------------------------------------- 9743-(9-88)
(7)
			 Dihydrocodeine---------------------------------------- 9120*
(8)
			 Diphenoxylate----------------------------------------- 9170*
(9) Fentanyl
			 ---------------------------------------------- 9801*
(10) Isomethadone
			 ------------------------------------------ 9226*
(11) Levo-alphacetylmethadol (LAAM)
			 ----------------------- 9648-(12-93)
(12) Levomethorphan
			 ---------------------------------------- 9210*
(13) Levorphanol
			 ------------------------------------------- 9220*
(14) Metazocine
			 -------------------------------------------- 9240*
(15) Methadone
			 --------------------------------------------- 9250*
(16) Methadone-Intermediate,
			 4-cyano-2-dimethylamino-4, 4-diphenyl butane -------------------
			 9254*
(17) Moramide-Intermediate,
			 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic
			 acid--------------------------------------- 9802*
(18) Pethidine (Meperidine)
			 ------------------------------- 9230*
(19) Pethidine-Intermediate-A,
			 4-cyano-1-methyl-4-phenylpiperidine ----------------------------
			 9232*
(20)
			 Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate
			 ----------------------- 9233*
(21)
			 Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid
			 ------------------- 9234*
(22)
			 Phenazocine ------------------------------------------9715*
(23) Piminodine
			 -------------------------------------------- 9730*
(24) Racemethorphan
			 ---------------------------------------- 9732*
(25) Racemorphan
			 ------------------------------------------- 9733*
(26)
			 Remifentanil------------------------------------------ 9739-(11-96)
(27) Sufentanil
			 -------------------------------------------- 9740-(9-81)
(d)
Stimulants
: Unless specifically excepted
			 or unless listed in another schedule, any material, compound, mixture, or
			 preparation which contains any quantity of the following substances having a
			 stimulant effect on the central nervous system:
(1) Amphetamine, its salts, optical isomers,
			 and salts of its optical isomers -------------------------------
			 1100*
(2) Methamphetamine, its
			 salts, isomers, and salts of its isomers
			 ----------------------------------------1105*
(3) Lisdexamefetamine
			 ------------------------------------- 1205*(7-07)
(4) Phenmetrazine and its salts
			 --------------------------1631*
(5)
			 Methylphenidate ---------------------------------------1724*
(e)
Depressants
: Unless specifically excepted
			 or unless listed in another schedule, any material, compound, mixture, or
			 preparation which contains any quantity of the following substances having a
			 depressant effect on the central nervous system, including its salts, isomers,
			 and salts of isomers whenever the existence of such salts, isomers, and salts
			 of isomers is possible within the specific chemical designation:
(1) Amobarbital
			 ------------------------------------------- 2125*
(2) Glutethimide
			 ------------------------------------------ 2550-(2-91)
(3) Pentobarbital
			 ----------------------------------------- 2270*
(4) Phencyclidine
			 ----------------------------------------- 7471*
(5) Secobarbital
			 ------------------------------------------ 2315*
(f)
Hallucinogenic
			 Substances:
(1) Nabilone
			 ---------------------------------------------- 7379-(11-87)
[Another name for
				nabilone:(+))trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-l-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pran-9-one].
(2) Dronabinol in an oral solution
			 in a drug product approved for marketing by the U.S.Food and Drug
			 Administration; [(-)
			 -delta-9-trans-tetrahydrocannabinol(delta-9-THC)].------7365
(g)
Immediate
			 Precursor
: Unless specifically excepted or unless listed in
			 another schedule, any material, compound, mixture, or preparation which
			 contains any quantity of the following substances:
(1) Immediate precursor to Amphetamine and
			 Methamphetamine:
(i) Phenylacetone
			 ------------------------------------ 8501-(3-80)
Some trade or other names: phenyl-2-propanone; P2P; benzyl
				methyl Ketone; methyl benzyl Ketone.
(2) Immediate precursor to Phencyclidine
			 (PCP):
(i) 1-phenylcyclohexylamine
			 ------------------------- 7460*
(ii) 1-piperidinocyclohexanecarbonitrile
			 (PCC) ------ 8603*
(3)
			 Immediate precursor to Fentanyl:
(i)
			 4-anilino-N-phenethylpiperidine(ANPP) ---------- 8333* (08-10)
Schedule III
(a) Schedule III shall consist of the drugs
			 and other substances, by whatever official name, common or usual name, chemical
			 name, or brand name designated, listed in this section. Each drug or substance
			 has been assigned the DEA Controlled Substances Code Number set forth opposite
			 it.
(b)
Stimulants
: Unless specifically excepted
			 or unless listed in another schedule, any material, compound, mixture, or
			 preparation which contains any quantity of the following substances having a
			 stimulant effect on the central nervous system, including its salts, isomers
			 (whether optical, position, or geometric), and salts of such isomers whenever
			 the existence of such salts, isomers, and salts of isomers is possible within
			 the specific chemical designation:
(1) Those
			 compounds, mixtures, or preparations in dosage unit form containing any
			 stimulant substances listed in Schedule II which compounds, mixtures, or
			 preparations were listed on August 25, 1971, as excepted compounds under
			 Section 308.32, and any other drug of the quantitative composition shown in
			 that list for those drugs or which is the same except that it contains a lesser
			 quantity of controlled substances --------------------------------------
			 1405*
(2) Benzphetamine
			 ---------------------------------------------- 1228*
(3) Chlorphentermine
			 ------------------------------------------- 1645*
(4) Clortermine
			 ------------------------------------------------- 1647*
(5) Phendimetrazine
			 --------------------------------------------1615*
(c)
Depressants
: Unless specifically excepted
			 or unless listed in another schedule, any material, compound, mixture, or
			 preparation which contains any quantity of the following substances having a
			 depressant effect on the central nervous system:
(1) Any compound, mixture, or preparation
			 containing:
(i) Amobarbital
			 -----------------------------------------2126*
(ii) Secobarbital
			 ----------------------------------------2316*
(iii) Pentobarbital
			 ---------------------------------------2271*
(iv) Embutramide
			 ----------------------------------------- 2020* (9-06)
or any salt thereof and one or more other active medicinal
				ingredients which are not listed in any schedule.
(2) Any suppository dosage form containing:
(i) Amobarbital
			 ----------------------------------------- 2126*
(ii) Secobarbital
			 ----------------------------------------2316*
(iii) Pentobarbital
			 ---------------------------------------2271*
or any salt of any of these drugs and approved by the Food and
				Drug Administration for marketing only as a suppository.
(3) Any substance which contains
			 any quantity of a derivative of barbituric acid or any salt thereof ----
			 2100*
(4) Chlorhexadol
			 -----------------------------------------------2510*
(5) Any drug product containing gamma
			 hydroxybutyric acid, including its salts, isomers, and salts of isomers, for
			 which an application is approved under section 505 of the Federal Food, Drug,
			 and Cosmetic Act -----------------------------------------------------------
			 2012-(2-01)
(6) Ketamine. its
			 salts, isomers, and salts of isomers ---7285-(7-99)
Some other names for Ketamine:
				(H-)-2-(2-Chlorophenyl)-2-(Methylamino)-Cyclohexanone.
(7) Lysergic acid
			 ---------------------------------------------- 7300*
(8) Lysergic acid amide
			 ---------------------------------------7310*
(9) Methyprylon
			 -------------------------------------------------2575*
(10) fondiethylmethane
			 ----------------------------------------- 2600*
(11) Sulfonethylmethane
			 ---------------------------------------- 2605*
(12) Sulfonmethane
			 ----------------------------------------------2610*
(13) Tiletamine and zolazepam or any salt
			 thereof ---------7295-(3-88)
Some trade or other name for a tiletamine-zolazepam combination
				product: Telazol. Some trade or other names for tiletamine:
				-2(ethylamino)-2-(2-thienyl)-cyclohexanone.
Some trade or other names for zolazepam:
				-4(2-fluorophenyl)-6,8-dihydro-1,3,8,-trimethylpyrazolo-[3,4-e]
				[1,4,]-diazepin-7 (1-H)-one. flupyrazapon.
(14) Perampanel
			 -------------------------------------------------- 2261-(11-13)
(d)
Nalorphine
------------------------------------------------------- 9400*
(e)
Narcotic
			 drugs
: Unless specifically excepted or unless listed in
			 another schedule:
(1) any material, compound,
			 mixture, or preparation containing any of the following narcotic drugs, or
			 their salts calculated as the free anhydrous base or alkaloid, in limited
			 quantities as set forth below:
(i) Not more
			 than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams
			 per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid
			 of opium ------------------------------------------------ 9803*
(ii) Not more than 1.8 grams of codeine per
			 100 milliliters or not more than 90 milligrams per dosage unit, with one or
			 more active, nonnarcotic ingredients in recognized therapeutic amounts
			 -------------------------------- 9804*
(iii) Not more than 1.8 grams of
			 dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage
			 unit, with one or more active nonnarcotic ingredients in recognized therapeutic
			 amounts -------------------------------- 9807*
(iv) Not more than 300 milligrams of
			 ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage
			 unit, with one or more active, nonnarcotic ingredients in recognized
			 therapeutic amounts -------------------------------- 9808*
(v) Not more than 500 milligrams of opium per
			 100 milliliters or per 100 grams or not more than 25 milligrams per dosage
			 unit, with one or more active nonnarcotic ingredients in recognized therapeutic
			 amounts -------------------------------- 9809*
(vi) Not more than 50 milligrams of morphine
			 per 100 milliliters or per 100 grams, with one or more active, nonnarcotic
			 ingredients in recognized therapeutic amounts --------------------------------
			 9810*
(2) Any material,
			 compound, mixture, or preparation containing any of the following narcotic
			 drugs or their salts, as set forth below:
(i)
			 Buprenorphine --------------------------------------- 9064-(6-85)10-02
			 Transfer)
(ii) Reserved
(f)
Anabolic Steroids
:
Unless specifically
			 excepted or unless listed in another schedule, any material, compound, mixture,
			 or preparation containing any quantity of the following substances, including
			 its salts, isomers, and salts of isomers whenever the existence of such salts
			 of isomers is possible within the specific chemical designation: Items 1-28
			 -------------------------- 4000-(9-91)
(1)
			 Boldenone;
(2) Boldione;
			 (01-10)
(3) Chlorotestosterone
			 (4-chlortestosterone);
(4)
			 Clostebol;
(5)
			 Dehydrochlormethy1testosterone;
(6)
			 Desoxymethyltestosterone (01-10)
(7) Dihydrotestosterone
			 (4-dihydrotestosterone);
(8)
			 Drostanolone;
(9)
			 Ethylestrenol;
(10)
			 Fluoxymesterone;
(11) Formebulone
			 (formebolone);
(12)
			 Mesterolone;
(13) Methandienone,
			 Methandrostenolone;
(14)
			 Methandranone;
(15)
			 Methandriol;
(16)
			 Methenolone;
(17) Methyl
			 testosterone;
(18)
			 Mibolerone;
(19)
			 Nandrolone;
(20)
			 19-Nor-4,9(10)-Androstadienedione (01-10)
(21) Norethandrolone;
(22) Oxandrolone;
(23) Oxymesterone;
(24) Oxymetholone;
(25) Stanolone;
(26) Stanozolol;
(27) Testolactone;
(28) Testosterone;
(29) Trenbolone
(30) Prostanozol
			 -------------------------------------- (8-12)
(31) Methasterone
			 ------------------------------------- (8-12); and
(32) Any salt, ester, or isomer of a drug or
			 substance described or list in this paragraph, if that salt, ester, or isomer
			 promotes muscle growth.
(1) Exempt
			 anabolic steroid products: Compounds, mixtures, or preparations that contain an
			 anabolic steroid that have been exempted by the Director:
NDC Number
(1)
			 Andro-Estro 90-4 ---------------------------------- 0536-1605
(2) Androgyn L.A.
			 ------------------------------------- 0456-1005
(3) Component E-H in Process Pellets
			 ----------------- Ivy Labs Inc.
(4)
			 Component E-H in Process Granulation ------------ Ivy Labs Inc.
(5) Component TE-S in process Granulation
			 ----------- Ivy Labs Inc.
(6)
			 Component TE-S in process Pellets ---------------- Ivy Labs Inc.
(7) depANDROGYN
			 --------------------------------------- 0456-1020
(8) Depo-Testadiol
			 ------------------------------------ 0009-0253
(9) DEPO-T.E.
			 ----------------------------------------- 52765-257
(10) depTESTROGEN
			 -------------------------------------- 51698-257
(11) Duomone
			 ------------------------------------------- 52 04 7-3 60
(12) DUO-SPAN II
			 --------------------------------------- 0684-0102
(13) DURATESTRIN
			 --------------------------------------- 43797-016
(14) Essian
			 -------------------------------------------- Pharmaceutics
(15) Essian H.S.
			 --------------------------------------- Pharmaceutics
(16) Esterified Estrogens &
			 Methyltestosterone, USP (0.625 mg/1.25mg)---------------------------------
			 Interpharm
(17) Esterified
			 Estrogens & Methyltestosterone, USP (1.25mg/2 .
			 5mg)------------------------------------ Interpharm
(18) Esterified Estrogens &
			 Methyltestosterone (0.625mg/1.25mg) Tablet --------------------------
			 ANDAPharm
(19) Esterified Estrogens
			 & Methyltestosterone (1.25mg/2.5mg) Tablet ----------------------------
			 ANDAPharm
(20) Estratest
			 ----------------------------------------- 0032-1026
(21) Estratest HS
			 -------------------------------------- 0032-1023
(22) Menogen
			 ------------------------------------------- 59243-570
(23) Menogen HS
			 ---------------------------------------- 59243-560
(24) Methyltestosterone & Esterified
			 Estrogens (2.5mg/1.25Mg) ------------------------------------ Lannett
			 Co
(25) Methyltestosterone &
			 Esterified Estrogens (Half Strength) (1.25mg/0. 625mg) ------------------------
			 Lannett Co
(26) PAN ESTRA TEST
			 ------------------------------------ 0525-0175
(27) Premarin with Methyltestosterone
			 ----------------- 0046-0879
(28)
			 Premarin with Methyltestosterone ----------------- 0046-0878
(29) Syntest D.S.
			 -------------------------------------- 66576-231
(30) Stntest H.S.
			 -------------------------------------- 66576-230
(31) Synovex H in process bulk pellets
			 ---------------- Syntex Animal
(32)
			 Synovex H in process granulation ----------------- Syntex Animal
(33) Synovex Plus in process granulation
			 ------------- Fort Dodge
(34)
			 Synovex Plus in process bulk pellets ------------ Fort Dodge
(35) TEST-ESTRO Cypionates
			 ---------------------------- 0536-9470
(36) Testoderm with Adhesive 4mg/d
			 -------------------- Alza Corp.
(37) Testoderm 4mg/d
			 ----------------------------------- 17314-4608
(38) Testoderm 6mg/d
			 -----------------------------------17314-4609
(39) Testoderm with Adhesive 6mg/d
			 -------------------- 17314-2836
(40) Testoderm in process film
			 ------------------------ Alza Corp.
(41) Testoderm with Adhesive in process film
			 --------- Alza Corp.
(42)
			 Testosterone Cypionate/Estradiol Cypionate injection
			 ----------------------------------------- 54274-530
(43) Testosterone Cypionate/Estradiol
			 Cypionate injection -----------------------------------------
			 0182-3069
(44) Testosterone Cyp 50
			 Estradiol Cyp 2-------------0814-7737
(45) Testosterone Cypionate/Estradiol
			 Cypionate injection ----------------------------------------
			 0364-6611
(46) Testosterone
			 Cypionate/Estradiol Cypionate injection
			 ---------------------------------------- 04 02-02 57
(47) Testosterone Enanthate/Estradiol
			 Valerate injection -----------------------------------------
			 0182-3073
(48) Testosterone
			 Enanthate/Estradiol Valerate injection
			 ----------------------------------------- 0364-6618
(49) Testosterone Enanthate/Estradiol
			 Valerate injection -----------------------------------------
			 0402-0360
(50) Testosterone
			 Ophthalmic Solution ----------------- Allergan
(51) Tilapia Sex Reversal Feed
			 (investigational) ----- Ranger, Inc.
(2) Veterinary Anabolic Steroid Implant
			 Products:
Anabolic steroid products expressly intended for administration
				through implants in cattle or other nonhuman species exempted by the
				Director.
NDC/DIN
(1) Component
			 E-H ------------------------------------ 021641-002
(2) Component E-H
			 ------------------------------------ 01968327
(3) Component TE-S
			 ----------------------------------- 021641-004
(4) Component T-H
			 ------------------------------------ 0211641-006
(5) Component T-S
			 ------------------------------------ 0211641-005
(6) F-TO
			 --------------------------------------------- 00093351
(7) Finaplix-H
			 --------------------------------------- 12799-807-10
(8) Finaplix-S
			 --------------------------------------- 12799-807-07
(9) Heifer-old
			 --------------------------------------- Boehringer
(10) Heifer-old
			 --------------------------------------- Ingelheim
(11) Heifer-old
			 --------------------------------------- Ivy Lab.
(12) Implus-H
			 ----------------------------------------- 0009-0434-01
(13) Implus-H
			 ----------------------------------------- 06-0434-01 01968327
(14) Masculinizing Feed for Fish
			 (Investigational) - Rangen,Inc.
(15) Revalor-G
			 ---------------------------------------- 12799-811
(16) Revalor-H
			 ---------------------------------------- 12799-810
(17) Revalor-S
			 ---------------------------------------- 12799-809
(18) Synovex H
			 ---------------------------------------- 0856-3901
(19) Synovex H
			 ---------------------------------------- Syntex
(20) Synovex Plus
			 ------------------------------------- 0856-3904
Tilapia Sex Reversal Feed (investigational) --------- Zeigier
				Bros.
If veterinary products that are granted exempted status are
				subsequently distributed with the intent that they be used in humans, the
				distribution would be subject to the criminal sanctions of the CSA despite the
				drugs' exempted status.
(g)
Hallucinogenic
			 substances
:
(1)
			 Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule
			 in a U.S. Food and Drug Administration approved drug product
			 -------------------------------------- 7369-(11-87)
[Some other names for dronabinol: (6a R-trans)-6a,7,8,
				10a-tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo [b,d] phyran-1-ol, or
				(-)-delta 9-(trans)-tetrahydrocannabinol]
Schedule IV
(a) Schedule IV shall consist of the drugs
			 and other substances, by whatever official name, common or usual name, chemical
			 name or brand name designated, listed in this section. Each drug or substance
			 has been assigned the DEA Controlled Substances Code Number set forth opposite
			 it.
(b)
Narcotic
			 drugs
: Unless specifically excepted or unless listed in
			 another schedule, any material, compound, mixture, or preparation containing
			 any of the following narcotic drugs, or their salts calculated as the free
			 anhydrous base or alkaloid, in limited quantities as set forth below:
(1) Not more than 1 milligram of difenoxin
			 and not less than 25 micrograms of atropine sulfate per dosage unit,
			 ------------------------------9167*
(2) Dextro propoxyphene
			 (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane) --------
			 9278-(11-87)
(c)
Depressants
: Unless specifically excepted
			 or unless listed in another schedule, any material, compound, mixture, or
			 preparation which contains any quantity of the following substances, including
			 its salts, isomers, and salts of isomers whenever the existence of such salts,
			 isomers, and salts of isomers is possible within the specific chemical
			 designation:
(1) Alprazolam
			 --------------------------------------------- 2882-(6-82)
(2) Barbital
			 ------------------------------------------ 2145*
(3) Bromazepam
			 ---------------------------------------- 2748-(1-85)
(4) Camazepam
			 ----------------------------------------- 2749-(1-85)
(5) Chloral betaine
			 ----------------------------------- 24 60*
(6) Chloral hydrate
			 ----------------------------------- 2465*
(7) Chlordiazepoxide
			 -------------------------------------- 2744*
(8) Clobazam
			 ----------------------------------------------- 2751-(1-85)
(9) Clonazepam
			 ---------------------------------------- 2737*
(10) Clorazepate
			 --------------------------------------- 2768*
(11) Clotiazepam
			 --------------------------------------- 2752-(1-85)
(12) Cloxazolam
			 ---------------------------------------- 2753-(1-85)
(13) Delorazepam
			 --------------------------------------- 2754-(1-85)
(14) Diazepam
			 ------------------------------------------ 2765*
(15) Dichloralphenazone
			 ------------------------------- 2467-(10-02)
(16) Estazolam
			 ---------------------------------------------- 2756-(1-85)
(17) Ethchlorvynol
			 ----------------------------------------- 2540*
(18) Ethinamate
			 ----------------------------------------2545*
(19) Ethyl loflazepate
			 ---------------------------------2758-(1-85)
(20) Fludiazepam
			 --------------------------------------------2759-(1-85)
(21) Flunitrazepam
			 -----------------------------------------2763-(1-85)
(22) Flurazepam
			 ---------------------------------------------2767*
(23) Fospropofol
			 ---------------------------------------------2138- (11-09)
(24) Halazepam
			 ---------------------------------------------- 2762-(6-82)
(25) Haloxazolam
			 -------------------------------------------- 2771-(1-85)
(26) Ketazolam
			 ---------------------------------------------- 2772-(1-85)
(27) Loprazolam
			 --------------------------------------------- 2773-(1-85)
(28) Lorazepam
			 ---------------------------------------------- 2885*
(29) Lormetazepam
			 ------------------------------------------- 2774-(1-85)
(30) Mebutamate
			 --------------------------------------------- 2800*
(31) Medazepam
			 ---------------------------------------------- 2836-(1-85)
(32) Meprobamate
			 -------------------------------------------- 2820*
(33) Methohexital
			 ------------------------------------------- 2264*
(34) Methylphenobarbital (mephorbarbital)
			 -------------- 2250*
(35) Midazolam
			 ---------------------------------------------- 2884-(1-85)
(36) Nimetazepam
			 -------------------------------------------- 2837-(1-85)
(37) Nitrazepam
			 --------------------------------------------- 2834-(1-85)
(38) Nordiazepam
			 -------------------------------------------- 2838-(1-85)
(39) Oxazepam
			 ----------------------------------------------- 2835*
(40) Oxazolam
			 ----------------------------------------------- 2839*
(41) Paraldehyde
			 -------------------------------------------- 2585*
(42) Petrichloral
			 ------------------------------------------- 2591*
(43)
			 Phenobarbital-----------------------------------------2285*
(44) Pinazepam
			 ---------------------------------------------- 2883-(1-85)
(45) Prazepam
			 ----------------------------------------------- 2764*
(46) Quazepam
			 ----------------------------------------------- 2881-(11-86)
(47) Temazepam
			 ---------------------------------------------- 2925-(9-81)
(48) Tetrazepam
			 --------------------------------------------- 2886-(1-85)
(49) Triazolam
			 ---------------------------------------------- 2887-(7-83)
(50) Zaleplon
			 ----------------------------------------------- 2781-(9-99)
(51) Zolpidem
			 ----------------------------------------------- 2783-(12-93)
(52) Zopiclone
			 ----------------------------------------------- 2784- (01-06)
(53) Alfaxalone
			 ---------------------------------------------- 2731- (02-14)
(54) Carisoprodol
			 ------------------------------------------- 8192-(4-97)
(55) Tramadol
			 ---------------------------------------------- 9752-(8-07)
(56) Suvorexant
			 --------------------------------------------- 2223-(8-14)
(d)
Fenfluramine
: Any material, compound,
			 mixture, or preparation which contains any quantity of the following
			 substances, including its salts, isomers (whether optical, position, or
			 geometric), and salts of such isomers, whenever the existence of such salts,
			 isomers, and salts of isomers is possible:
(1) Fenfluramine
			 -------------------------------------------- 1670*
(e)
Stimulants
: Unless specifically excepted
			 or unless listed in another schedule, any material, compound, mixture, or
			 preparation which contains any quantity of the following substances having a
			 stimulant effect on the central nervous system, including its salts, isomers
			 (whether optical, position, or geometric), and salts of such isomers whenever
			 the existence of such salts, isomers, and salts of isomers is possible within
			 the specific chemical designation:
(1) Cathine
			 ( ( + )-Norpseudeophedrine) --------------------- 1230-(3-88)
(2) Diethylpropion
			 ----------------------------------------- 1610*
(3) Fencamfamin
			 --------------------------------------------- 1760-(3-88)
(4) Fenproporex
			 --------------------------------------------- 1575-(3-88)
(5) Mazindol
			 ------------------------------------------------ 1605-(6-82)
(5) Mefenorex
			 -----------------------------------------------1580-(3-88)
(6) Modafinil
			 ------------------------------------------------ 1680-(1-99)
(7) Pemoline (including organometallic
			 complexes and chelates thereof) ---------------------------------
			 1530*
(9) Phentermine
			 --------------------------------------------- 1640*
(10) Pipradrol
			 ----------------------------------------------- 1750-(9-81)
(11) Sibutramine
			 --------------------------------------------- 1675-(2-98)
(12) SPA
			 ((-)-1-dimethylamino-1,2,diphenylethane) ------ 1635-(9-81)
(13) Lorcaserin
			 ---------------------------------------------- 1625-(6-13)
(f)
Other
			 substances
:
Unless specifically excepted or unless listed
			 in another schedule, any material, compound, mixture, or preparation which
			 contains any quantity of the following substances, including its salts; isomers
			 whether optical, position, or geometric), and salts of such isomers, whenever
			 the existence of such salts, isomers, and salts of isomers is possible:
(1) Pentazocine
			 --------------------------------------------- 9709-(4-79)
(2) Butorphanol
			 --------------------------------------------- 9720-(4-97)
(3) Nalbuphine
			 ---------------------------------------------- (4-97)
(4) Eluxadoline
			 --------------------------------------------- 9725
Schedule V
(a) Schedule V shall consist of the drugs and
			 other substances by whatever official name, common or usual name, chemical
			 name, or brand name designated, listed in this section.
(b)
Narcotic
			 Drugs
: Unless specifically excepted or unless listed in
			 another schedule, any material, compound, mixture or preparation containing any
			 of the following narcotic drugs and their salts, as set forth below.
Reserved
(c)
Narcotic drugs
			 containing nonnarcotic active medicinal ingredients
. Any
			 compound, mixture, or preparation containing any of the following limited
			 quantities of narcotic drugs or salts thereof, which shall include one or more
			 nonnarcotic active medicinal ingredients in sufficient proportion to confer
			 upon the compound, mixture, or preparation valuable medicinal qualities other
			 than those possessed by the narcotic drug alone:
*
			 (1) Not more than 200 milligrams of codeine per 100
			 milliliters or per 100 grams.
* (2)
			 Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
			 grams.
* (3) Not more than 100
			 milligrams of ethylmorphine per 100 milliliters or per 100 grams.
* (4) Not more than 2.5 milligrams of
			 diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage
			 unit.
* (5) Not more than 100
			 milligrams of opium per 100 milliliters or per 100 grams.
*
			 (6) Not more than 0.5 milligrams of difenoxin and not
			 less than 25 micrograms of atropine sulfate per dosage unit.
(d)
Stimulants
: unless specifically excepted
			 or unless listed in another schedule, any material, compound, mixture, or
			 preparation which contains any quantity of the following substances having
			 stimulant effect on the central nervous system, including its salts, isomers
			 and salts of isomers:
(1) Pyrovalerone
			 -------------------------------------------- 1485-(3-88)
(2) Ephedrine:a
			 -{-(Methylamino)ethyl}benzene-methanol; (10-95) a-{-(methylamino) ethyl} benzyl
			 alcohol;
2 -methylamino-1-phenyl-1-propanol;
1 -phenyl-1-hydroxy-2-methylaminopropane;
1 -phenyl-2-methylaminopropanol;
a - hydroxy-b-methylaminopropylbenzene;
a product which occurs in the Chinese herb Ma Huang (Ephedra
				vulgaris, Ephedra sinica Stapf., Ephedra equisetina Bunge, Gnetaceae) in
				several other Ephedra spp.
(3) Phenylpropanolamine
			 ------------------------------------- (7-05)
(4) Pseudoephedrine
			 ----------------------------------------- (7-05)
Pursuant to Ark. Code Ann. § 5-64-212 as amended in 2005,
				this Schedule V classification shall NOT apply to any ephedrine,
				phenylpropanolamine, or pseudoephedrine in liquid, liquid capsule, or liquid
				gel capsule form. However, sales limits mandated by statute shall apply to all
				products with ephedrine, phenylpropanolamine, or pseudoephedrine as a listed
				ingredient regardless of the dosage form.
(e)
Depressants:
Unless
			 specifically exempted or excluded or unless listed in another schedule, any
			 material, compound, mixture, or preparation which contains any quantity of the
			 following substances having a depressant effect on the central nervous system,
			 including its salts, isomers, and salts of isomers:
(1) Pregabalin
			 [(S)-3-(aminomethyl)-5-methylhexanoic acid) ---------------------------------
			 2782-(01-06)
(2) Lacosamide
			 ---------------------------------------------- 2746-(05-09)
(3) Brivaracetam
			 -------------------------------------------- 2710
(f)
Other substances:
(1) A drug product in finished dosage
			 formulation that has been approved by the U.S. Food and Drug Administration
			 that contains cannabidiol(2-[1R-3-methyl
			 -6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1, 3-benzenediol) derived
			 from cannabis and no more than 0.1 percent (w/w) residual
			 tetrahydrocannabinols.
Schedule VI**
(a) In addition to any substance placed in
			 Schedule VI by the Director of the Department of Health under § 5-64-214,
			 any material, compound, mixture, or preparation, whether produced directly or
			 indirectly from a substance of vegetable origin or independently by means of
			 chemical synthesis, or by a combination of extraction and chemical synthesis,
			 that contains any quantity of the following substances, or that contains any of
			 their salts, isomers, and salts of isomers when the existence of the salts,
			 isomers, and salts of isomers is possible within the specific chemical
			 designation, is included in Schedule VI:
(1)
			 Marijuana
(2)
			 Tetrahydrocannabinols, unless the tetrahydrocannabinol is:
(A) Contained in hemp-derived
			 cannabidiol;
(B) Not more than
			 three-tenths of one percent (0.3%)of the hemp-derived cannabidiol on a dry
			 weight basis as verified by a nationally accredited laboratory for quality,
			 purity and accuracy standards; and
(C) Not approved by the United States Food
			 and Drug Administration for marketing as a medication;
(3) A synthetic equivalent of:
(A) The substance contained in the Cannabis
			 plant; or
(B) The substance
			 contained in the resinous extractives of the genus Cannabis;
(4) Salvia divinorum or Salvinorin
			 A, which includes all parts of the plant presently classified botanically as
			 Salvia divinorum, whether growing or not, the seeds of the plant, any extract
			 from any part of the plant, and every compound, manufacture, derivative,
			 mixture, or preparation of the plant, its seeds, or its extracts, including
			 salts, isomers, and salts of isomers when the existence of the salts, isomers,
			 and salts of isomers is possible within the specific chemical
			 designation;
(5) Synthetic
			 substances, derivatives, or their isomers in the chemical structural classes
			 described below in subdivisions (a)(5)(A)-(J) of this section and also specific
			 unclassified substances in subdivision (a)(5)(K) of this section. Compounds of
			 the structures described in this subdivision (a)(5), regardless of numerical
			 designation of atomic positions, are included in this subdivision (a) (5) . The
			 synthetic substances, derivatives, or their isomers included in this
			 subdivision (a)(5) are:
(A)
(i) Tetrahydrocannabinols, including without
			 limitation the following:
(a) Delta-1 cis or
			 trans tetrahydrocannabinol, and its optical isomers;
(b) Delta-6 cis or trans
			 tetrahydrocannabinol, and its optical isomers; and
(c) Delta-3.4 cis or trans
			 tetrahydrocannabinol, and its optical isomers.
(ii) Dronabinol in sesame oil and
			 encapsulated in a soft gelatin capsule in a drug product approved by the United
			 States Food and Drug Administration is not a tetrahydrocannabinol under this
			 subdivision (a)(5)(A);
(B) Naphthoylindoles, or any compound
			 structurally derived from 3-(1-naphthoyl) indole or 1H-indol-3-yl-(1-naphthyl)
			 methane by substitution at the nitrogen atom of the indole ring by alkyl,
			 haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
			 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl)ethyl group, whether or
			 not further substituted in the indole ring to any extent and whether or not
			 substituted in the naphthyl ring to any extent, including without limitation
			 the following
(i) JWH-007, or
			 1-pentyl-2-methyl-3-(1-naphthoyl)indole;
(ii) JWH-015, or
			 1-Propyl-2-methyl-3-(1-naphthoyl)indole;
(iii) JWH-018, or
			 1-Propyl-3-(1-naphthoyl)indole;
(iv) JWH-019, or 1-Hexyl-3-(1-naphthoyl)
			 indole;
(v) JWH-073, or
			 1-Butyl-3-(1-naphthoyl) indole;
(vi) JWH-081, or
			 1-Pentyl-3-(4-methoxy-1-naphthoyl) indole;
(vii) JWH-098, or
			 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl) indole
(viii) JWH-122, or
			 1-Pentyl-3-(4-methyl-1-naphthoyl) indole;
(ix) JWH-164, or
			 1-pentyl-3-(7-methoxy-1-naphthoyl) indole;
(x) JWH-200, or
			 1-[2-(4-morpholiny)ethyl]-3-(1-naphthoyl) indole;
(xi) JWH-210, or
			 1-Pentyl-3-(4-ethyl-1-naphthoyl) indole;
(xii) JWH-398, or
			 1-Pentyl-3-(4-chloro-1-naphthoyl) indole;
(xiii) AM-2201, or
			 1-(5-fluoropentyl)-3-(1-naphthoyl) indole;
(xiv) MAM2201, or
			 (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone;
			 and
(xv) EAM2201, or
			 (1-(5-fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)-methanone;
(xvi) THJ-2201, or
			 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl) methanone;
(C) Naphthylmethylindoles, or any
			 compound structurally derived from an H-indol-3-yl-(1-naphthyl) methane by
			 substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl,
			 alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl
			 or 2-(4-morpholinyl) ethyl group, whether or not further substituted in the
			 indole ring to any extent and whether or not substituted in the naphthyl ring
			 to any extent, including without limitation the following:
(i) JWH-175, or
			 1-Pentyl-1H-indol-3-yl-(1-naphthyl) methane; and
(ii) JWH-184, or
			 1-Pentyl-1H-3-yl-(4-methyl-1-naphthyl) methane;
(D) Naphthoylpyrroles, or any compound
			 structurally derived from 3-(1-naphthoyl)pyrrole by substitution at the
			 nitrogen atom of the pyrrole ring by alkyl, haloalkyl, alkenyl,
			 cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or
			 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole
			 ring to any extent and whether or not substituted in the naphthyl ring to any
			 extent, including without limitation JWH-307, or
			 (5-(2-fluorophenyl)-l-pentylpyrrol-3-yl)-naphthalen-1-ylmethanone;
(E) Naphthylmethylindenes, or any compound
			 structurally derived from 1-(1-napthylmethyl)indene with substitution at the
			 3-position of the indene ring by an alkyl, haloalkyl, alkenyl,
			 cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or
			 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene
			 ring to any extent and whether or not substituted in the naphthyl ring to any
			 extent, including without limitation JWH-176, or
			 E-1-[1-(1-Naphthalenylmethylene)-1H-inden-3-yl]pentane;
(F) Phenylacetylindoles, or any compound
			 structurally derived from 3-phenylacetylindole by substitution at the nitrogen
			 atom of the indole ring with alkyl, haloalkyl, alkenyl,
			 cycloalkylmethyl,cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or
			 2-(4-morpholinyl)ethyl group whether or not further substituted in the indole
			 ring to any extent and whether or not substituted in the phenyl ring to any
			 extent, including without limitation the following:
(i) JWH-201, or
			 2-(4-methoxyphenyl)-1-(1-pentylindol-3-yl) ethanone;
(ii) JWH-203, or
			 1-Pentyl-3-(2-chlorophenylacetyl) indole;
(iii) JWH-250, or
			 1-Pentyl-3-(2-methoxyphenylacetyl) indole;
(iv) JWH-251, or
			 1-Pentyl-3-(2-methylphenylacetyl) indole; and
(v) RCS-8, or
			 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl) indole;
(G) Cyclohexylphenols, or any compound
			 structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the
			 5-position of the phenolic ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl,
			 cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl
			 group, whether or not substituted in the cyclohexyl ring to any extent,
			 including without limitation the following:
(i) CP 47,497
			 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol;
(ii) Cannabicyclohexanol or CP 47,497 C8
			 homologue, or 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol;
			 and
(iii) CP 55,940, or
			 5-(1,1-dimethylheptyl)-2-[(1R,2R)-5-hydroxy-2-(3-hydroxypropyl)
			 cyclohexyl]-phenol;
(H)
			 Benzoylindoles, or any compound structurally derived from a 3-(benzoyl)indole
			 structure with substitution at the nitrogen atom of the indole ring by alkyl,
			 haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
			 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or
			 not further substituted in the indole ring to any extent and whether or not
			 substituted in the phenyl ring to any extent, including without limitation the
			 following:
(i) AM-694, or
			 1-(5-fluoropentyl)-3-(2-iodobenzoyl) indole;
(ii) RCS-4, or 1-Pentyl-3-(4-methoxybenzoyl)
			 indole;
(iii) WIN-48,098 or
			 Pravadoline, or (4-Methoxyphenyl)-[2-methyl-1-(2-(4-morpholinyl)ethyl)
			 indol-3-y]methanone;
(iv) AM-2233,
			 or 1-[(N-methylpiperidin-2-yl)methyl]-3-(2-iodobenzoyl)indole; and
(v) RCS-4 (C4 homologue) or
			 (4-methoxyphenyl)(1-butyl-1H-indol-3-yl)-methanone;
(I) Adamantoylindoles, or
			 Adamantoylindazoles, including Adamantyl Carboxamide Indoles and Adamantyl
			 Carboxamide Indazoles, or any compound structurally derived from
			 3-(1-adamantoyl) indole, 3-(1-adamantoyl) indazole, or 3-(2-adamantoyl) indole
			 by substitution at a nitrogen atom of the indole or indazole ring with alkyl,
			 haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl,
			 cycloalkylethyl, 1-(N-methyl-2-piperidinyl) methyl or 2-(4-morpholinyl) ethyl,
			 whether or not further substituted in the indole or indazole ring to any extent
			 and whether or not substituted in the adamantly ring to any extent, including
			 without limitation the following:
(i)
			 AM-1248, or 1-adamantyl-[1-[(1-methylpiperidin-2-yl) methyl] indol-3-yl]
			 methanone;
(ii) AB-001, or
			 1-adamantyl-(1-pentylindol-3-yl)methanone;
(iii) JWH-018 adamantyl carboxamide, or
			 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indole-3-carboxamide, some other
			 names: 2NE1;
(iv) AKB-48, or
			 N-(1-adamantyl)-pentyl-1H-indazole-3-carboxamide;
(v) 5F-AKB-48, or
			 N-((3s,5s,7s)-adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide;
(vi) STS-135, or
			 N-(1-adamantyl)-1-(5-fluoropentyl)indole-3-carboxamide;
(J) Tetramethylcyclopropylcarbonyl indoles or
			 any compound structurally derived from
			 3-(2,2,3,3-tetramethylcyclopropylcarbonyl) indole by substitution at the
			 nitrogen atom of the indole ring with alkyl,haloalkyl, alkenyl, cyanoalkyl,
			 hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)
			 methyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the
			 indole ring to any extent, including without limitation the following:
(i) UR-144, or
			 (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl) methanone;
(ii) XLR-11, or
			 [1-(5-fluoropentyl)-1H-indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)
			 methanone;
(iii) A-796,260, or
			 [1-(2-morpholin-4-yl-ethyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)
			 methanone;
(iv) 5-Chloro-UR-144, or
			 ([-(5-chloropentyl)-1H-indol-3-yl]
			 (2,2,3,3-tetramethylcyclopropyl)methanone;
(v) 5-Bromo-UR-144, or
			 [1-(5-bromopentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone;
			 and
(vi) A-834,735, or
			 1-(tetrahydropyran-4-ylmethyl)-1H-indol-3-yl]-(2 ,
			 2,3,3-tetramethylcyclopropyl)methanone;
(K) Unclassified Synthetic Cannabinoids,
			 including without limitation the following:
(i) CP 50556-1 hydrochloride, or
			 [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl]
			 acetate;
(ii) HU-210, or
			 (6aR,lOaR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
(iii) HU-211, or
			 Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
(iv) Dimethylheptylpyran or
			 DMHP;
(v) WIN55,212-2, or
			 2,3-Dihydro-5-methyl-3-( 4-morpholinylmethyl)
			 pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl-1-naphthalenylmethanone;
(vi) URB597, or [3-(3-carbamoylphenyl)phenyl]
			 N-cyclohexylcarbamate;
(vii)
			 URB754, or 6-methyl-2-[(4-methylphenyl)amino]-1-benzoxazin-4-one;
(viii) CB-13, or
			 1-naphthalenyl[4-(pentyloxy)-1 naphthalenyl]-methanone;
(ix) URB602, or cyclohexyl
			 N-(3-phenylphenyl)carbamate;
(x)
			 PB-22, or quinolin-8-yl 1-(5-pentyl)-1H-indole-3-carboxylate;
(xi) 5F-PB-22, or quinolin-8-yl
			 1-(5-fluoropentyl)-1H-indole-3-carboxylate;
(xii) BB-22, or quinolin-8-yl
			 1-(cyclohexylmethyl)-1H-indole-3-carboxylate;
(xiii) NNEI (MN-24), or
			 N-1-naphthalenyl-l-pentyl-lH-indole-3-carboxamide;
(xiv) 5F-NNEI, or
			 1-(5-fluoropentyl)-N-(naphthalene-1-yl)-1H-indole-3-carboxamide;
(xv) 5-Fluoro-AMB, or
			 n-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-L-valine methyl
			 ester;
(xvi) MMB-CHMICA,or
			 methyl-(1-cyclohexylmethyl)-1H-indole-3-carbonyl)-L-valinate;
(xvii) 5-Fluoro-ADB, or methyl
			 2-(1-(5-fluoropentyl)-1H-
			 indazole-3-carboxamido)-3,3-dimethylbutanoate;
(xviii) 5-Fluoro-MDMB-PICA, or methyl
			 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate;
(xix) MDMB-CHMICA, or methyl
			 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate;
(xx) FUB-AMB, or methyl
			 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate;
(xxi) MDMB-FUBINACA, or methyl
			 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate;
(xxii) AB-PINACA, or
			 N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-caroboxamide;
(xxiii) AB-CHMINACA, or
			 N-(1-amino-3-methyl-1-oxobutan-
			 2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide;
(xxiv) MAB-CHMINACA, or
			 N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide;
(xxv) AB-FUBINACA, or
			 N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide;
(xxvi) ADB-PINACA, or
			 N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-lH-indazole-3-carboxamide;
(xxvii) 5F-CUMYL-PINACA, or
			 1-(5-fluoropenLyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide.
(6) A synthetic
			 substance, derivative, or its isomers with:
(A) Similar chemical structure to any
			 substance described in subdivisions (a)(1)-(5) of this section; or
(B) Similar pharmacological effects to any
			 substance described in subdivisions (a)(1)-(5) of this section.
(b) However, director
			 shall not delete a controlled substance listed in this section from Schedule
			 VI.
(c)
(1) If notice has been given to the director
			 that the United States Food and Drug Administration has designated,
			 rescheduled, or descheduled a marijuana-derived substance under federal law and
			 approved for marketing the marijuana-derived substance as a prescription
			 medication, the director shall consider the designation, rescheduling, or
			 descheduling of the marijuana-derived substance under this chapter.
*-Scheduled before April, 1979.
**-Schedule VI is revised to conform to Act 329 of
				2013.